LBTD.US Lotus Bio-Technology Development Corp
- Market cap
- USD 6.71M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2023.
Is LBTD.US undervalued?
Graham numberThe Graham number of Lotus Bio-Technology Development Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lotus Bio-Technology Development Corp fundamental analysis
No fundamental analysis for Lotus Bio-Technology Development Corp yet.
Lotus Bio-Technology Development Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lotus Bio-Technology Development Corp. was incorporated in 2011 and is based in Por…
Full company profileLotus Bio-Technology Development Corp financial statements
Lotus Bio-Technology Development Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - |
| Operating Income | -62.1K | -41.6K | -18.7K | -781K | -19.6K | - | - | - | - | - |
| EBITDA | -62.1K | -41.6K | -18.7K | -780K | -18.5K | - | - | - | - | - |
| Net Income | -62.1K | -41.6K | -18.7K | -781K | -19.6K | - | - | - | - | - |
| EPS | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 | - | - | - | - | - |
| Balance Sheet | ||||||||||
| Total Assets | 4.07K | 105.00 | 1.51K | 5.46K | 1.00 | - | - | - | - | - |
| Total Liabilities | 13.3K | 52.2K | 46.7K | 66.8K | 80.9K | - | - | - | - | - |
| Shareholders' Equity | -9.28K | -52.1K | -45.2K | -61.3K | -61.3K | - | - | - | - | - |
| Cash & Short-term Investments | 4.07K | 105.00 | 1.51K | 5.00 | 1.00 | - | - | - | - | - |
| Total Debt | 12.0K | 33.9K | - | 51.5K | 6.45K | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -72.2K | -24.6K | 1.50K | -8.44K | -17.8K | - | - | - | - | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 6.55K | 0.00 | - | - | - | - | - |
| Free Cash Flow | -72.2K | -24.6K | 1.50K | -15.0K | -17.8K | - | - | - | - | - |
| Ratios | ||||||||||
| ROA | -1,527.1% | -39,660.0% | -1,244.1% | -14,296.2% | -1,955,000.0% | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
Lotus Bio-Technology Development Corp dividends
Lotus Bio-Technology Development Corp has not paid dividends in the last 7 fiscal years.
Last stock split: 30:1 on Jun 26, 2014.
Who owns Lotus Bio-Technology Development Corp
- Insiders 60.40%
- Institutions 0.00%
- Public & others 39.60%
- Shares outstanding 671M
- Free float 249M
Lotus Bio-Technology Development Corp company profile
- Company name
- Lotus Bio-Technology Development Corp
- Ticker
- LBTD.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Media (discontinued effective close of September 28, 2018)
- Fiscal year end
- March
- Address
- 2559 Parkview Lane, Port Coquitlam, BC, Canada, V3c6m1
- Phone
- 778 814 7729
- Website
- www.lotusbiotechnologies.com
About Lotus Bio-Technology Development Corp
Lotus Bio-Technology Development Corp. does not have significant operations. The company intends to seek opportunities in the Organic and Bio-technology space. Previously, it is engaged in refining organic materials, and production of natural consumer related products. The company was formerly known as Starflick.com and changed its name to Lotus Bio-Technology Development Corp. in April 2016. Lotus Bio-Technology Development Corp. was incorporated in 2011 and is based in Port Coquitlam, Canada.
Lotus Bio-Technology Development Corp management
2- Mr. Zoltan NagyPresident, CFO, Principal Accounting Officer, Treasurer & Secretary · born 1966
- Mr. Hoyt ChristopherChief Executive Officer